Biopharma

Healthier Diets, Lower Waist-to-Hip Ratio in Midlife Im...

TUESDAY, March 18, 2025 -- Healthier diets and lower waist-to-hip ratio (WHR) t...

Botox Intervention Improves Facial Asymmetry After Nerv...

TUESDAY, March 18, 2025 -- For patients with severe oral commissure droop from ...

Breastfeeding, Avoiding Sugary Drinks Reduce Later Obes...

TUESDAY, March 18, 2025 -- Adequate breastfeeding (BF) and avoidance of sugary ...

ACC: Cannabis Use Linked to Increased Risk for MI in Pe...

TUESDAY, March 18, 2025 -- Cannabis use is associated with an increased risk fo...

Disparities Seen in Older Adults' Access to Rehab After...

TUESDAY, March 18, 2025 -- Disparities exist in access to rehabilitation follow...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Efavirenz/Emtricitabin...

Prime sets sights on liver, lung disease as next target...

The biotech unveiled a new research program in alpha-1 antitrypsin deficiency, a...

Stoke CEO exits; Medicare drug price talks advance

Ed Kaye, Stoke’s longtime leader, will be replaced by former Vertex executive Ia...

Lilly, J&J, Pfizer and Sanofi back Teva fight against I...

In a proposed amicus brief, Eli Lilly, Johnson & Johnson, Pfizer and Sanofi have...

Sequel Med Tech connects twiist insulin pump to Abbott’...

Greenlit for people ages six and older with Type 1 diabetes, Sequel’s twiist sys...

IRA round 2 begins as drugmakers sign on to price negot...

All of the drugmakers that market the 15 drugs selected for the second cycle of ...

Opinion on medicine for use outside EU: Ivermectin/Albe...

Opinion on medicine for use outside EU: Ivermectin/Albendazole, ivermectin,alben...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Riarify (previously CH...

It’s Dr. Oz’s turn to tout AI on the Hill

In this edition of STAT's Health Tech newsletter: Dr. Oz touting the benefits of...

STAT+: A little-known HHS agency may face big layoffs

A little-known HHS agency may face big layoffs, FDA employees return to the offi...

Novartis plans 427 layoffs in New Jersey as looming Ent...

Novartis is laying off 427 employees in East Hanover, New Jersey, where the comp...

Fierce Biotech Layoff Tracker 2025: HC Bioscience set t...

As always, if you know of layoffs occurring at a biotech, please reach out to th...

Sarepta reports 1 death after patient received DMD gene...

One patient with Duchenne muscular dystrophy has passed away following treatment...

Arch-backed HC Bioscience closes doors after seeing ear...

The Cambridge, Massachusetts-based biotech is closing “following careful conside...

Duchenne patient dies after receiving Sarepta gene therapy

A young man treated with Elevidys died of acute liver failure. The case may give...

Novartis plots 427 layoffs in New Jersey as looming Ent...

Novartis is laying off 427 employees in East Hanover, New Jersey, where the comp...

Vincerx, left in limbo by collapsed deal, moves to merg...

Vincerx Pharma has found a fast fix for the uncertainty over its future. Recentl...

Fierce Biotech Fundraising Tracker '25: Arbor adds $74M...

The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...

Variations requiring assessment (veterinary medicines)

Variations requiring assessment (veterinary medicines)

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.